FDA Status
Not FDA-Approved
Halted before Phase I due to preclinical safety findings
Claimed Benefits
- Anabolic potency in animal models
- Cell culture supplement
- Muscle wasting prevention (preclinical)
Clinical Evidence
No Published Human Clinical Trials
Never advanced to human trials due to unmanageable hypoglycemia from insulin receptor cross-activation in preclinical tests.
Read Full Deep Dive
Mechanism, dosing, vendor pricing, and full research citations